search
Back to results

Dynamic Infrared Thermography in Breast Cancer Diagnostics

Primary Purpose

Breast Cancer

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
FLIR ThermaCAM P-65
Sponsored by
University Hospital of North Norway
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Breast Cancer focused on measuring Sensitivity, Specificity, Breast cancer, Mammography, Thermography, Infrared, Dynamic, Diagnostic accuracy, Diagnostic odds ratio

Eligibility Criteria

50 Years - 69 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • women,
  • aged 50-69
  • attending the Norwegian Breast Screening Program,
  • recalled for assessment after positive mammography screening

Exclusion Criteria:

  • not attending the Norwegian Breast Screening Program,
  • recalled to mammography for other reason than positive screening mammogram.

Sites / Locations

  • Åshild Odden Miland

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Thermography and mammography

Arm Description

All participants will be examined with Dynamic infrared thermography (FLIR ThermaCAM P-65) Mammography, clinical examination and if necessary breast tissue biopsy to diagnose breast cancer.

Outcomes

Primary Outcome Measures

Diagnostic accuracy of Thermography compared with Mammography and breast biopsy.
Can thermography distinguish benign from malign tumours in breast cancer diagnostics. The gold standard is breast biopsy pathology. The outcome is measured as number of subjects with pathological diagnosis of cancer.

Secondary Outcome Measures

Full Information

First Posted
April 12, 2016
Last Updated
July 7, 2016
Sponsor
University Hospital of North Norway
search

1. Study Identification

Unique Protocol Identification Number
NCT02829021
Brief Title
Dynamic Infrared Thermography in Breast Cancer Diagnostics
Official Title
Dynamic Infrared Thermography in Breast Cancer Diagnostics. A Diagnostic Accuracy Study Comparing Dynamic Infrared Thermography Against Mammography (Reference Standard)
Study Type
Interventional

2. Study Status

Record Verification Date
June 2016
Overall Recruitment Status
Completed
Study Start Date
April 2009 (undefined)
Primary Completion Date
June 2012 (Actual)
Study Completion Date
June 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital of North Norway

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluate diagnostic accuracy of dynamic infrared thermography compared to mammography (reference test) in breast cancer diagnostics. Women aged 50-70 years, selected for assessment after mammography screening were invited to dynamic infrared thermography before clinical mammography and further examination.
Detailed Description
This study evaluate diagnostic accuracy of dynamic infrared thermography compared to mammography (reference test) in breast cancer diagnostics. Dynamic infrared thermography (DIRT) is an imagine procedure offering a non-invasive, painless examination without risk of radiation. Dynamic infrared thermography does not provide information on the morphological characteristics of the breast, rather it provides functional information on thermal and vascular conditions of the tissue (Fitzgerald, 2012). During the study period from April 2009 until June 2012, a total of 168 women aged 50-70 years who were recalled for assessment after positive mammography screening were offered dynamic infrared thermography before further tests (clinical mammography, clinical examination and if necessary breast tissue biopsy). Radiographers at the Breast Diagnostic Center (BDS) at University Hospital North Norway collected information about parity, menopausal status, use of hormone therapy and size of bra. The same radiographers also carried out all the dynamic infrared thermography examinations. PI Åshild O. Miland and Professor James B. Mercer interpreted the thermograms and entered the data into the thermography database. Both were blinded for further assessments (mammography, clinical examination and biopsy) and non of them talked to any of the participants after the examination. The health professionals who were responsible for the women during mammography, clinical examination and biopsy were blinded for the results from the infrared digital thermography examination. They were not allowed to ask the women about the infrared digital thermography examination. The three radiologists at BDS made the interpretation of the mammographies and entered data into the digital patient journal and to the mammography database at The Norwegian Cancer Registry. One of the radiologist took, when necessary, breast biopsies. A breast surgeons were responsible for the clinical breast examination. Pathologists verified the histology. Breast radiologist Jan Ole Frantzen and researcher Merethe Kumle, MD, PhD collected information about breast cancer results from the digital patient journal and Roentgen information system (RIS) and entered it into a separate mammography database. The thermography database and the mammography database was still not merged at the time of registration in ClinicalTrials.gov (March 2015).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
Sensitivity, Specificity, Breast cancer, Mammography, Thermography, Infrared, Dynamic, Diagnostic accuracy, Diagnostic odds ratio

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
168 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Thermography and mammography
Arm Type
Other
Arm Description
All participants will be examined with Dynamic infrared thermography (FLIR ThermaCAM P-65) Mammography, clinical examination and if necessary breast tissue biopsy to diagnose breast cancer.
Intervention Type
Device
Intervention Name(s)
FLIR ThermaCAM P-65
Other Intervention Name(s)
Serial number: 25300659
Intervention Description
Women recalled for assessment after positive screening mammography were offered dynamic infrared thermography before clinical mammography and further tests.
Primary Outcome Measure Information:
Title
Diagnostic accuracy of Thermography compared with Mammography and breast biopsy.
Description
Can thermography distinguish benign from malign tumours in breast cancer diagnostics. The gold standard is breast biopsy pathology. The outcome is measured as number of subjects with pathological diagnosis of cancer.
Time Frame
Baseline

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
69 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: women, aged 50-69 attending the Norwegian Breast Screening Program, recalled for assessment after positive mammography screening Exclusion Criteria: not attending the Norwegian Breast Screening Program, recalled to mammography for other reason than positive screening mammogram.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Åshild O. Miland, PhD
Organizational Affiliation
Senior lecturer
Official's Role
Principal Investigator
Facility Information:
Facility Name
Åshild Odden Miland
City
Tromsø
ZIP/Postal Code
9037
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
This is a small Diagnostic Accuracy Study, the investigators will decide upon data sharing when they have finished the statistical analysis. If someone is interested in the data, please contact the investigators.

Learn more about this trial

Dynamic Infrared Thermography in Breast Cancer Diagnostics

We'll reach out to this number within 24 hrs